VERACYTE, INC. — Director's Dealing 2019

Dec 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2019-12-05

Reporting Person: Kennedy Giulia C (Chief Scientific & Med Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-05	Common Stock	M	32803	$14.34	Acquired	79665	Direct
2019-12-05	Common Stock	S	32803	$29.3919	Disposed	46862	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-05	Stock Option (right to buy)	$14.34	M	32803	Disposed	2024-02-18	Common Stock (32803.0)	Direct

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019.

F2: Represents weighted average sales price. Sale prices for the transactions range from $29.34 to $29.56. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F3: The option is fully vested.